Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025 LONDON, May 13, 2025 (GLOBE NEWSWIRE) ...

Giullia Coradetti, MD, offered insight into her research on a post-hoc analysis based on the GATHER 2 clinical trial data for geographic atrophy and age-related macular degeneration.

Get our top picks of the posters at AACR 2025 and learn more about the method behind them and the techniques used.

Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL ...

Agendia®, Inc., today announced that new data from its ongoing FLEX Study will be presented at the upcoming ESMO Breast ...

Safety and functionality data for the updated Liquid Biopsy System supports continuation of the BIOPATTERN trial ...

One poster presents a new analysis of data from the Visceral Adiposity Measurement and Observations Study (VAMOS), in which EVAF was associated with reduced muscle quality in aging PWH.

Data support planned dosing regimen and protocol for FIH study to initiate in mid-2025LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Axovia Therapeutics Ltd., a biotechnology company developing therapies to ...

One poster presents a new analysis of data from the Visceral Adiposity Measurement and Observations Study (VAMOS), in which EVAF was associated with reduced muscle quality in aging PWH. VAMOS is the ...